Tadalafil Tablet, Film Coated
Product Images NDC 76420-856

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 76420-856). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 01)

Chemical structure of tadalafil, the active ingredient in this human prescription drug tablet. The diagram displays the molecular arrangement of tadalafil included in the product label by Asclemed USA, Inc.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 02)

A set of four line graphs depicting the difference in systolic and diastolic blood pressure (BP) between tadalafil and placebo over time, measured in hours. The graphs compare standing systolic BP, standing diastolic BP, supine systolic BP, and supine diastolic BP, with BP differences shown on the y-axis and time on the x-axis.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 03)

Two line graphs showing the effects on systolic blood pressure over 24 hours post-dose. The top graph depicts standing systolic blood pressure changes for Tadalafil 20 mg with doxazosin 8 mg versus placebo with doxazosin 8 mg. The bottom graph shows supine systolic blood pressure changes for the same treatments.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 04)

A line graph depicting systolic blood pressure (BP) changes over 12 hours after administration of tadalafil or placebo combined with doxazosin at two dosing times, 08:00 and 20:00. The vertical axis represents systolic BP in mmHg, and the horizontal axis represents time after administration in hours, comparing multiple treatment groups.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 05)

A pharmacokinetic line graph showing plasma tadalafil concentration (µg/L) over time (hours). The graph compares single 20 mg and 5 mg tadalafil doses and once-daily 5 mg tadalafil following 5 consecutive days of administration, with concentration decreasing over extended time periods up to 120 hours. Error bars indicate variability in plasma concentration measurements.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 06)

A line graph showing change from baseline in IPSS total score over 12 weeks of treatment. The graph compares tadalafil 5 mg and placebo groups, with the tadalafil group showing a greater decrease in score. The x-axis represents treatment duration (weeks), and the y-axis represents change from baseline in IPSS total score. Statistical significance is noted at p<0.01.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 07)

A line graph comparing the change from baseline in IPSS total score over a 12-week treatment duration between Tadalafil 5 mg and placebo groups. The graph shows a greater decrease in IPSS score for the Tadalafil 5 mg group compared to placebo, with statistically significant differences indicated.*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 08)

A line graph illustrating the least-squares mean change from baseline over 26 weeks of therapy comparing Tadalafil/Finasteride and Placebo/Finasteride. The x-axis represents weeks of therapy at intervals (0, 4, 12, 26), and the y-axis shows the LS mean change from baseline with decreasing values indicating greater change. The graph shows two lines with markers representing treatment groups and includes statistical significance indicators (p-values).*

FDA Label Image

Image (2c3d64d3 27b6 4ec1 Bd71 7c6bab4cd31d 09)

A line graph comparing the change from baseline in IPSS total score over a 12-week treatment duration between Tadalafil 5 mg and placebo. The x-axis represents treatment duration in weeks, and the y-axis shows the change from baseline in IPSS total score. The Tadalafil group shows a greater decrease in score over time compared to placebo, with a significant difference indicated (p<0.01).*

FDA Label Image

Label (Tadalafil 10mg)

This image shows multiple packaging labels for Tadalafil Tablets USP 10 mg, film coated oral tablets. Labels include varying quantities such as 30, 60, 90, 100, and 500 tablets. The labels indicate packaging and relabeling by Enovachem Pharmaceuticals, with manufacturing by Unichem Pharmaceuticals (USA). Each label features the NDC 76420-856 followed by various suffixes, barcode, QR code, storage instructions, and caution about prescription-only dispensing.*

FDA Label Image

Label (Tadalafil 2 5mg)

Multiple pharmaceutical labels for Tadalafil Tablets USP 2.5 mg, film-coated tablets in various package sizes including 30, 60, 90, 100, and 500 count. Labels show the product is relabeled or packaged by Enovachem Pharmaceuticals with information on NDC codes, manufacturing source, and storage instructions. The design includes barcodes and cautionary statements about prescription use and storage conditions.*

FDA Label Image

Label (Tadalafil 20mg)

Labels for Tadalafil Tablets, USP 20 mg, film-coated tablets in various quantities (30, 60, 90, 100, 500). Labels show the Enovachem Pharmaceuticals logo and include NDC numbers, manufacturer Unichem Pharmaceuticals (USA), INC., and packaging or relabeling information by Enovachem Pharmacy. The tablets are described as yellow, almond-shaped, film-coated, debossed, with storage and prescription caution information.*

FDA Label Image

Label (Tadalafil 5mg)

Labels for tadalafil tablets USP 5 mg from Enovachem Pharmaceuticals relabeled and packaged by Asclemed USA, Inc. The labels show package quantities of 30, 60, 90, 100, and 500 tablets. They include NDC numbers, serialization codes, and storage instructions to keep out of reach of children and maintain controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.